Morrhage: a prospective randomized study. J Neurosurg 2002, 97:77178. eight. Starke RM, Kim GH, Fernandez A, Komotar RJ, Hickman ZL, Otten ML, Ducruet AF, Kellner CP, Hahn DK, Chwajol M, Mayer SA, Connolly ES Jr: Influence of a protocol for acute antifibrinolytic therapy on aneurysm rebleeding just after subarachnoid hemorrhage. Stroke 2008, 39:2617621. 9. Starke RM, Connolly ES Jr: Rebleeding right after aneurysmal subarachnoid hemorrhage. Neurocrit Care 2011, 15:24146. 10. Roos YB, Beenen LF, Groen RJ, Albrecht KW, Vermeulen M: Timing of surgery in patients with aneurysmal subarachnoid haemorrhage:11.12.13.14.15.16.17. 18.19.20. 21.rebleeding is still the major cause of poor outcome in neurosurgical units that aim at early surgery. J Neurol Neurosurg Psychiatry 1997, 63:49093. Laidlaw JD, Siu KH: Ultra-early surgery for aneurysmal subarachnoid hemorrhage: outcomes for a consecutive series of 391 sufferers not chosen by grade or age. J Neurosurg 2002, 97:25058. Phillips TJ, Dowling RJ, Yan B, Laidlaw JD, Mitchell PJ: Does therapy of ruptured intracranial aneurysms inside 24 hours strengthen clinical outcome Stroke 2011, 42:1936945. Lamb JN, Crocker M, Tait MJ, Anthony BB, Papadopoulos MC: Delays in treating sufferers with superior grade subarachnoid haemorrhage in London. Br J Neurosurg 2011, 25:24348. Roos YB, Rinkel GJ, Vermeulen M, Algra A, Van GJ: Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev 2003, two:CD001245. Gaberel T, Magheru C, Emery E, Derlon JM: Antifibrinolytic therapy in the management of aneurismal subarachnoid hemorrhage revisited. A meta-analysis. Acta Neurochir (Wien) 2012, 154:1. Connolly ES Jr, Rabinstein AA, Carhuapoma JR, Derdeyn CP, Dion J, Higashida RT, Hoh BL, Kirkness CJ, Naidech AM, Ogilvy CS, Patel AB, Thompson BG, Vespa P, American Heart Association Stroke Council; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; Council on Cardiovascular Surgery and Anesthesia; Council on Clinical Cardiology: Recommendations for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare experts in the American Heart Association/american Stroke Association. Stroke 2012, 43:1711737. Rankin J: Cerebral vascular accidents in patients more than the age of 60. II. Prognosis. Scott Med J 1957, two:20015. Janssen PM, Visser NA, DorhoutMees SM, Klijn CJ, Algra A, Rinkel GJ: Comparison of telephone and face-to-face assessment of the modified Rankin Scale. Cerebrovasc Dis 2010, 29:13739. Ronne-Engstrom E, Enblad P, Lundstrom E: Outcome immediately after spontaneous subarachnoid hemorrhage measured with the EQ-5D. Stroke 2011, 42:3284286. Schulz KF, Grimes DA: Multiplicity in randomised trials II: subgroup and interim analyses. Lancet 2005, 365:1657661. Roberts I, Perel P, Prieto-Merino D, Shakur H, Coats T, Hunt BJ, Lecky F, Brohi K, Willett K: Impact of tranexamic acid on mortality in sufferers with traumatic bleeding: prespecified evaluation of information from randomised controlled trial.DSP Crosslinker Antibody-drug Conjugate/ADC Related BMJ 2012, 345:e5839.D-Fructose-6-phosphate disodium web doi:10.PMID:23618405 1186/1745-6215-14-143 Cite this article as: Germans et al.: Ultra-early tranexamic acid immediately after subarachnoid hemorrhage (ULTRA): study protocol to get a randomized controlled trial. Trials 2013 14:143.Submit your subsequent manuscript to BioMed Central and take complete benefit of:Easy on-line submission Thorough peer evaluation No space constraints or colour figure charges Quick publication on acceptance Inclusion in PubMed, CAS, Scopus and Google Scholar Research which.